End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,240 KRW | +0.38% | +1.35% | -9.03% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
Sales 2012 | 84.46B 62.34M 85.31M | Sales 2013 * | - | Capitalization | 120B 88.43M 121M |
---|---|---|---|---|---|
Net income 2012 * | - | Net income 2013 * | - | EV / Sales 2012 | 0.8 x |
Net cash position 2012 * | - 0 0 | Net cash position 2013 * | - 0 0 | EV / Sales 2013 * | - |
P/E ratio 2012 * |
-
| P/E ratio 2013 * |
-
| Employees | 290 |
Yield 2012 * |
-
| Yield 2013 * |
-
| Free-Float | 66.36% |
1 day | +0.38% | ||
1 week | +1.35% | ||
Current month | +0.96% | ||
1 month | -4.73% | ||
3 months | -4.73% | ||
6 months | -24.06% | ||
Current year | -9.03% |
Managers | Title | Age | Since |
---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Chan-Tae Ko
AUD | Comptroller/Controller/Auditor | 65 | - |
Bong-Rim Cho
PRN | Corporate Officer/Principal | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Young-Ryul Lee
BRD | Director/Board Member | 66 | 19-03-28 |
Won-Gyoon Na
BRD | Director/Board Member | 38 | 22-03-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 5,240 | +0.38% | 24,642 |
24-05-02 | 5,220 | +0.58% | 78,682 |
24-04-30 | 5,190 | +0.39% | 23,060 |
24-04-29 | 5,170 | 0.00% | 33,415 |
End-of-day quote Korea S.E., May 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-9.03% | 88.44M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- A002210 Stock